|
Outcome
|
Baseline
|
3 weeks
|
12 weeks/3 months
|
|---|
|
Feedback
|
No Feedback
|
Feedback
|
No feedback
|
Feedback
|
No feedback
|
|---|
|
M (SD)
|
Median (range)
|
M (SD)
|
Median (range)
|
M (SD)
|
Median (range)
|
M (SD)
|
Median (range)
|
M (SD)
|
Median (range)
|
M (SD)
|
Median (range)
|
|---|
|
Performance-based
|
|
Grip strength (Kg)
|
|
Right
|
21 (13.2)
| |
24 (13.1)
| |
20 (13.7)
| |
25 (13.6)
| | | | | |
|
Left
|
19 (11.7)
| |
17 (11.2)
| |
23 (9.3)
| |
15 (10.1)
| | | | | |
|
10-m walk test (s)
|
43 (31.8)
| |
40 (32.3)
| |
37 (34.5)
| |
48 (41.8)
| | | | | |
|
MoCA
|
17 (5.6)
|
18 (9–28)
|
17 (6.4)
|
21 (7–26)
|
19 (7.4)
|
22 (6–28)
|
18 (6.4)
|
21 (7–26)
| | | | |
|
BI
|
9 (4.0)
|
8 (5–18)
|
11 (4.2)
|
11 (5–21)
|
12 (3.7)
|
12 (6–19)
|
12 (4.4)
|
13 (7–20)
| | | | |
|
Self-report
|
|
FSS
| |
39 (9–50)
| |
48 (9–60)
| |
40 (33–55)
| |
52 (20–63)
| | | | |
|
VAF-S
| |
6 (0–10)
| |
8 (0–10)
| |
5 (3–10)
| |
7 (5–10)
| | | | |
|
EQ-5D-5L VAS
|
47.9 (24.9)
|
52 (10–90)
|
55 (29.6)
|
60 (0–100)
|
52 (24.5)
|
57 (0–80)
|
61 (26.0)
|
70 (20–100)
|
55 (24.2)
|
50 (30–90)
|
60 (10.2)
|
60 (50–75)
|
|
RMI
| |
4 (1–13)
| |
6 (2–15)
| |
8 (1–14)
| |
6 (3–15)
| |
8 (3–15)
| |
9 (0–14)
|
|
WHODAS
| |
48 (12–85)
| |
54 (16–87)
| |
46 (4–79)
| |
44 (20–95)
| |
39 (2–60)
| |
45 (4–79)
|
- Data were included only if the patient successfully completed assessment.
- Abbreviations: MoCA, Montreal Cognitive Assessment (Mandarin version); BI, Barthel ADL Index; FSS, Fatigue Severity Scale; VAF-S, Visual Analog Fatigue Scale; EQ-5D-5L, EuroQol Health Questionnaire, including the EQ VAS (Visual Analogue Scale); RMI, Rivermead Mobility Index; WHODAS, World Health Organization Disability Assessment Schedule (12-item); M, mean; SD, standard deviation. WHODAS scores represent a percentage of the maximum disability score (the total score, between 0 and 48, is divided by 48 and multiplied by 100)
